Russell 2000 Analysis: 3 Stocks with Stagnant Sales and Operational Challenges - News and Statistics
This article analyzes three Russell 2000 companies—Lindsay Corporation, ICU Medical, Inc., and Enact Holdings, Inc.—that are experiencing stagnant sales and operational challenges. Lindsay faces flat sales and diminishing returns on capital, ICU Medical struggles with stagnant sales, a projected decline, and increased capital intensity, and Enact Holdings has seen stagnant net premiums and lagging EPS growth. The report highlights these firms due to their common pattern of sales stagnation and specific cyclical headwinds.
DEC 11·Investing.com▲
Lindsay secures $80 million irrigation deal for Middle East, North Africa
Lindsay Corporation has secured an $80 million deal to provide Zimmatic irrigation systems and FieldNET technology to the Middle East and North Africa (MENA) region, aiming to boost food production and security. The company expects to recognize approximately $70 million of this revenue in fiscal year 2026. This comes after Lindsay reported a Q4 2025 earnings miss and announced a share repurchase program and a new management incentive plan, while maintaining its quarterly dividend.
DEC 11·Stock Titan▲
Lindsay (NYSE: LNN) secures $80M MENA irrigation deal, sees $70M revenue in FY26
Lindsay Corporation announced an $80 million supply agreement to provide irrigation systems and remote management technology in the Middle East and North Africa (MENA) region. This project, supporting localized food production, anticipates approximately $70 million of the total contract revenue to be recognized in fiscal year 2026. Randy Wood, CEO, highlighted the company's role as a trusted partner in advancing sustainable agriculture and enhancing food security.
